{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:56:35Z","timestamp":1760784995005,"version":"3.40.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Science and Technology Department","award":["2019B110233002"],"award-info":[{"award-number":["2019B110233002"]}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"crossref","award":["202002030431"],"award-info":[{"award-number":["202002030431"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an inhibitory receptor that is expressed on the surface of multiple immune cells and plays key roles in immune modulation. In patients with chronic hepatitis B (CHB), T cell number and functions are abnormal and the expression of inhibitory receptors is elevated. However, the expression of LAIR-1 on T cells in patients with CHB is still undetermined.<\/jats:p>\n            <jats:p>We recruited 320 patients with CHB in different disease phases and 17 healthy donors. Serum biochemical and virological examinations were performed for each participant, and their demographic and clinical data were collected. According to the latest American Association for the Study of Liver Disease guidelines, we categorized the patients into 4 groups: immune active, immune tolerant, inactive CHB, and gray zone. Additionally, we tested the expression of LAIR-1 on T cells and T cell subsets using flow cytometry.<\/jats:p>\n            <jats:p>We observed a significant decrease in LAIR-1 expression on CD3+ T cells and its two subsets (CD4+ and CD8+ T cells) in patients with CHB. LAIR-1 expression on T cells was the lowest in the immune active group. LAIR-1 expression levels on CD4+ and CD8+ T cells showed a significant negative association with hepatitis B virus (HBV) DNA load and were lower in hepatitis B e antigen (HBeAg)-positive patients than in HBeAg-negative patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). In addition, LAIR-1 expression levels on CD3+, CD4+, and CD8+ T cells were all negatively associated with liver inflammation and fibrosis parameters, such as alanine aminotransferase and aspartate aminotransferase levels, FibroScan value, and aspartate aminotransferase-to-platelet ratio index score.<\/jats:p>\n            <jats:p>LAIR-1 expression levels on T cells were associated with HBV DNA load and liver inflammation and fibrosis parameters, indicating that LAIR-1 may play an important regulatory role in HBV-induced T cell immune pathogenesis and may be a therapeutic target for CHB.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026667","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T20:01:47Z","timestamp":1628193707000},"page":"e26667","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients"],"prefix":"10.1097","volume":"100","author":[{"given":"Yurong","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-8622","authenticated-orcid":false,"given":"Yanhua","family":"Bi","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wei","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zexuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixin","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehua","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"},{"name":"Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2013.7","article-title":"The liver works as a school to educate regulatory immune cells","volume":"10","author":"Li","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2017.03.049","article-title":"Chronic hepatitis B: immunological profile and current therapeutic vaccines in clinical trials","volume":"35","author":"Lobaina","year":"2017","journal-title":"Vaccine"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1038\/emi.2013.14","article-title":"T-cell responses in hepatitis B and C virus infection: similarities and differences","volume":"2","author":"Schmidt","year":"2019","journal-title":"Emerg Microb Infect"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-11-22","article-title":"Innate immune responses in hepatitis B virus (HBV) infection","volume":"11","author":"Busca","year":"2014","journal-title":"Virol J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J Virol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3349\/ymj.2012.53.5.875","article-title":"Hepatitis B precore protein: pathogenic potential and therapeutic promise","volume":"53","author":"Walsh","year":"2012","journal-title":"Yonsei Med J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2005.12.022","article-title":"Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans","volume":"45","author":"Sprengers","year":"2006","journal-title":"J Hepatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1189\/jlb.0907609","article-title":"The inhibitory collagen receptor LAIR-1 (CD305)","volume":"83","author":"Meyaard","year":"2008","journal-title":"J Leukoc Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1189\/jlb.0705370","article-title":"Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation","volume":"79","author":"Verbrugge","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbrc.2003.09.152","article-title":"9.1C3 is identical to LAIR-1, which is expressed on hematopoietic progenitors","volume":"310","author":"Ouyang","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1074\/jbc.RA119.011150","article-title":"Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway","volume":"295","author":"Park","year":"2020","journal-title":"J Biol Chem"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/intimm\/9.9.1271","article-title":"p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes","volume":"9","author":"Poggi","year":"1997","journal-title":"Int Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.molimm.2005.01.004","article-title":"The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation","volume":"42","author":"Maasho","year":"2005","journal-title":"Mol Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/eji.200636678","article-title":"Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation","volume":"37","author":"Jansen","year":"2007","journal-title":"Eur J Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e31903","DOI":"10.1371\/journal.pone.0031903","article-title":"Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients","volume":"7","author":"Colombo","year":"2012","journal-title":"PLoS One"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41598-017-00290-w","article-title":"Evidence for C1q-mediated crosslinking of CD33\/LAIR-1 inhibitory immunoreceptors and biological control of CD33\/LAIR-1 expression","volume":"7","author":"Son","year":"2017","journal-title":"Sci Rep"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cellimm.2013.12.005","article-title":"The role of LAIR-1 (CD305) in T cells and monocytes\/macrophages in patients with rheumatoid arthritis","volume":"287","author":"Zhang","year":"2014","journal-title":"Cell Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.currproblcancer.2018.04.005","article-title":"Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma","volume":"43","author":"Wu","year":"2019","journal-title":"Curr Probl Cancer"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2015.01.127","article-title":"Leukocyte-associated immunoglobulin-like receptor-1 expressed in epithelial ovarian cancer cells and involved in cell proliferation and invasion","volume":"458","author":"Cao","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hed.25539","article-title":"LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma","volume":"41","author":"Yang","year":"2019","journal-title":"Head Neck"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.molimm.2011.09.006","article-title":"Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1","volume":"49","author":"Rygiel","year":"2011","journal-title":"Mol Immunol"},{"key":"R28-20250504","first-page":"03","article-title":"Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijms20205080","article-title":"The good and the bad of natural killer cells in virus control: perspective for anti-HBV therapy","volume":"20","author":"Fisicaro","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and co-inhibitory pathways in autoimmunity","volume":"44","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12967-017-1318-1","article-title":"Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment","volume":"15","author":"Li","year":"2017","journal-title":"J Transl Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"e1008459","DOI":"10.1371\/journal.ppat.1008459","article-title":"Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation","volume":"16","author":"Luo","year":"2020","journal-title":"PLoS Pathog"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8\u200aT cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/apt.13802","article-title":"Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006\u20132013","volume":"44","author":"Spradling","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12072-015-9657-6","article-title":"Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection","volume":"10","author":"Wang","year":"2016","journal-title":"Hepatol Int"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmi.2014.10.002","article-title":"Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection","volume":"21","author":"Song","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/MD.0000000000000322","article-title":"Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study","volume":"93","author":"Jia","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/IDR.S163038","article-title":"Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs","volume":"11","author":"Cai","year":"2018","journal-title":"Infect Drug Resist"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"2974753","DOI":"10.1155\/2019\/2974753","article-title":"Expression of LAIR-1 (CD305) on human blood monocytes as a marker of hepatic cirrhosis progression","volume":"2019","author":"Martinez-Esparza","year":"2019","journal-title":"J Immunol Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B","volume":"143","author":"Kennedy","year":"2012","journal-title":"Gastroenterology"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1743-422X-8-113","article-title":"Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection","volume":"8","author":"Wu","year":"2011","journal-title":"Virol J"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8\u200aT cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molimm.2007.07.038","article-title":"PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients","volume":"45","author":"Peng","year":"2008","journal-title":"Mol Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:35:36Z","timestamp":1746336936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026667"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":46,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026667","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"2021-03-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}